|
iCRO: AI - driven and central imaging services for oncology drug development 2025 Key Achievements (unaudited figures) Median s order backlog 1 and revenue come entirely from the iCRO Business Unit, ...
01Net
-
19-1-2026
|
|
|
|
... supporting efforts to accelerate clinical development, enhance biomarker discovery, and enable the next wave of data - driven decision - making across the pipeline. Oncology drug development is ...
01Net
-
13-1-2026
|
|
|
|
... representing ~83% growth year - over - year, including ~30% organic growth (excluding Ambry) Diagnostics revenue of ~$955 million, representing ~111% growth year - over - year, driven by Oncology ...
01Net
-
12-1-2026
|
|
|
|
...biopharma partnerships that accelerated enrollment across interventional and observational oncology ... whose background in AI - driven care and reimbursement strategy adds valuable perspective to the ...
01Net
-
8-1-2026
|
|
|
|
... the company integrates machine - learning - driven selectivity, proteomics - based secretome ... with additional opportunities across oncology and viral infections enabled by the same underlying ...
01Net
-
8-1-2026
|
|
|
|
About Guardant Health Guardant Health is a leading precision oncology company focused on guarding ... patient - centered research and evidence - driven advocacy. GHLF reaches more than 700,000 patients ...
01Net
-
29-12-2025
|
|
|
|
- - (BUSINESS WIRE) - - Valar Labs, a leader in AI - powered diagnostics for oncology, today ... allowing urologists and oncologists to incorporate AI - driven prognostic and predictive insights into ...
01Net
-
22-12-2025
|
|
|
|
|
|
Gli articoli sono stati selezionati e posizionati in questa pagina in modo automatico.
L'ora o la data visualizzate si riferiscono al momento in cui l'articolo è stato aggiunto o aggiornato in Libero 24x7
